Prevention of cytomegalovirus infection and disease in high-risk renal transplant recipients with polyvalent intravenous immunoglobulins.
Séchet
A
A
Service Nephrologie, CHU La Pieirre, Poitiers, France.
Bridoux
F
F
Bauwens
M
M
Ayache
R Abou
RA
Belmouaz
S
S
Touchard
G
G
D003587:Cytomegalovirus / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000502:physiology*; D011183:Postoperative Complications / Q000821:virology*; D012189:Retrospective Studies; D012307:Risk Factors
D016756:Immunoglobulins, Intravenous